Johnson & Johnson
American multinational pharmaceutical and consumer goods corporation
Johnson & Johnson ▸ Facts ▸ Comments ▸ News ▸ Videos
Johnson & Johnson (J&J) is an American multinational, pharmaceutical, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.
0 shares | ShareTweetSavePostSend |
You Might Like
After court win to make baby powder, J&J gives up licenceThree years since ceasing production of its talc-based powders in the US and Canada, pharmaceutical giant Johnson and Johnson recently surrendered its licence to manufacture baby powder in its Mumbai..IndiaTimes - Published | |
Johnson & Johnson agrees to pay $8.9bn to settle claims that talc caused cancerJohnson & Johnson (J&J) has agreed to pay almost $9bn (£7.2bn) to settle tens of thousands of lawsuits alleging its talc caused cancer.Sky News - Published | |
Johnson & Johnson’s set to lose patent on key TB drug in JulyIn one of the most-watched patent cases in recent times, the Indian Patent Office on Thursday rejected American giant Johnson & Johnson’s (J&J) attempt to extend its monopoly on life-saving TB drug..IndiaTimes - Published | |
HC quashes J&J baby powder manufacture ban over FDA test delayIndiaTimes - Published | |
Make, but don't sell: HC on J&J powderThe Bombay HC on Wednesday ordered for fresh testing of Johnson & Johnson baby powder samples and permitted the company to manufacture the product but to not sell it, as per the Maharashtra government..IndiaTimes - Published | |
Maharashtra FDA cancels Johnson & Johnson baby powder licence over poor qualityThe judgment was made after the Central Drugs Laboratory in Kolkata agreed with the Maharashtra FDA's 2019 report deeming the goods sub-standard.DNA - Published | |
Johnson & Johnson to end global sales of talc-based baby powderJohnson & Johnson has announced it will stop selling talc-based baby powder globally in 2023, more than two years after it ended US sales due to thousands of consumer safety lawsuits.Sky News - Published | |
Opioid epidemic: Native American tribes reach settlements of $590m with J&J and three distributorsNative American tribes have reached settlements of $590m (£436m) with a pharmaceutical company and three distribution firms over the toll of opioids.Sky News - Published | |
India set to get first J&J Covid vaccine doses in October, says sourceIndia expects to get its first Johnson & Johnson Covid-19 vaccine doses from next month, filled and finished in India by a partner of the US drugmaker, a source with knowledge of the matter told..IndiaTimes - Published | |
‘J&J should prioritise supply of locally-made Covid-19 jabs to India’IndiaTimes - Published | |
Johnson & Johnson's single-shot vaccine likely to be rolled out in India by OctoberJohnson & Johnson's single-shot vaccine was the fifth vaccine to get Emergency Use Approval for use in India by Drug Controller General on August 7.DNA - Published | |
Johnson and Johnson seeks nod to study Covid-19 vaccine among kids in IndiaIndiaTimes - Published | |
Covid-19: Johnson & Johnson seeks approval to conduct vaccine trials for 12-17 age groupJohnson & Johnson has submitted an application to the central drugs standard control organisation (CDSCO) to conduct a study of its Covid-19 vaccine in India in adolescents aged 12-17 years.IndiaTimes - Published | Johnson & Johnson's single-dose Covid vax gets emergency use nodIndiaTimes - Published Also reported by •DNA |
Johnson and Johnson’s Covid-19 vaccine gets nod for emergency use in IndiaIndia has approved Johnson & Johnson's single-dose CoviD-19 vaccine for emergency use on Saturday, health minister Mansukh Mandaviya said in a tweet. This will further boost the country's collective..IndiaTimes - Published Also reported by •DNA | Johnson & Johnson applies for Emergency Use Authorization of its single-dose Covid vaccine in IndiaJohnson & Johnson has applied for Emergency Use Authorization (EUA) of its single-dose Covid-19 vaccine in India, the global healthcare major said on Friday.IndiaTimes - Published Also reported by •DNA |
J&J withdraws plea to hold vaccine trials as govt relaxes normsIndiaTimes - Published | 'J&J withdraws proposal for speedy vaccine approval in India'IndiaTimes - Published |
Ben Crump Sues J&J Over 'Cancerous' Talcum Powder Targeted at Black WomenBen Crump is suing Johnson & Johnson for allegedly targeting Black women with a product he says has been linked to cancer -- and it sounds like they're going class action with this. The civil rights..TMZ.com - Published | Indemnity issue holds up J&J, Pfizer and Moderna jabsIndiaTimes - Published |
Covid-19: Wrong injection technique could also be leading to clotsA new study shows that wrong injection technique could be one of the reasons behind clotting following inoculation by adeno virus-based Covid vaccines, which include AstraZeneca, J&J and Sputnik jabs...IndiaTimes - Published | Covid-19: Govt talking to J&J over single-dose jabThe government is in talks with Johnson & Johnson regarding their single-dose vaccine and as per the plan, this vaccine will also be produced by Hyderabad's Biological E, NITI Aayog member-health Dr V..IndiaTimes - Published |
India to get Johnson & Johnson's single-dose COVID-19 vaccine soon?Appreciating the Janssen vaccine, Dr VK Paul said, "It is a good single-dose vaccine. Single doses can be used to complete the full course."DNA - Published | Discussions on to speed up vaccine delivery: J&JIndiaTimes - Published |
J&J explores ways to speed up delivery of its Covid-19 vaccine in IndiaJohnson & Johnson (J&J) said on Tuesday it was in talks with the Indian government to explore ways to speed up delivery of its single-shot Covid-19 vaccine in the country. The Economic Times newspaper..IndiaTimes - Published | Johnson & Johnson COVID-19 vaccine likely to be available in India by July - price and other details hereThe efficacy of the vaccine developed by Johnson and Johnson is 66.3% for mild to moderate COVID-19 and 76.3% for severe to critical infection.DNA - Published |
Moderna offers to sell booster shots from January; indemnity-waiver talks onUS vaccine maker Moderna has offered to sell booster doses of its Covid vaccine to India, from January 2022 even as the government continues to hold negotiations with Moderna and J&J on the indemnity..IndiaTimes - Published | India in talks with Pfizer, J&J, Moderna for local manufacturing of COVID vaccines: Harsh Vardhan ShringlaLast month saw India getting the first batches of Suptink V vaccines, which will be also produced by Indian companies.DNA - Published |
US Supreme Court rejects Johnson & Johnson appeal of $2bn talc verdictThe US Supreme Court has declined to hear Johnson & Johnson's appeal against a $2.12bn (£1.5bn) damages award to women who say they developed ovarian cancer from using the company's talc products.Sky News - Published | How does the newly-approved Johnson & Johnson COVID vaccine work - and how does it compare?The Johnson & Johnson (J&J) vaccine is the fourth coronavirus jab approved for use in the UK.Sky News - Published |
Johnson & Johnson single-dose vaccine approved for use in the UKThe Johnson & Johnson single-dose coronavirus vaccine has been approved for use in the UK, the medicines regulator has said.Sky News - Published | Govt looking into securing part of Johnson & Johnson vaccines for Indian market: SourcesIndiaTimes - Published |
Anti-Vaxxer Steals COVID Vaccine Vials in Bizarre ConfrontationAn anti-vaxxer has been going around stealing vials of the Johnson & Johnson COVID vaccine, proclaiming it poisonous and urging people to turn their backs on it. It's a bizarre story. A guy named..TMZ.com - Published | US panel recommends resuming Johnson & Johnson COVID-19 vaccineA US medical panel has recommended resuming the use of the Johnson & Johnson COVID-19 vaccine.Sky News - Published |
Johnson & Johnson's Covid vaccine expected to be imported by June-July: Science and technology ministryIndiaTimes - Published | Johnson & Johnson COVID vaccine could be linked to rare blood clots, EU regulator saysThe European Medicines Agency says it has found a possible link between the Johnson & Johnson COVID vaccine and very rare cases of unusual blood clots.Sky News - Published |
India paves way for foreign Covid-19 vaccines: Side effects, risks of Pfizer, Moderna, Sputnik, J&JIndiaTimes - Published | Pfizer, J&J vaccine rollout in India could take a few monthsUS pharma giants Pfizer, Johnson & Johnson, and Novavax could be among the potential gainers from the government’s decision on Tuesday to fast-track approvals for foreign-produced Covid-19 vaccines..IndiaTimes - Published |
Covid-19 vaccine: Pfizer, J&J entry could still be months awayUS pharma biggies Pfizer, Johnson & Johnson and Moderna could be amongst the potential gainers of the government’s decision to fast-track approvals for foreign-produced Covid-19 vaccines. While..IndiaTimes - Published | India seeks imports of Covid vaccines as cases soarIndia is to fast-track emergency approvals for Covid-19 vaccines that have been authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson, and Moderna..IndiaTimes - Published |
European rollout of Johnson & Johnson COVID jab delayed as US officials investigate clotsThe rollout of the Johnson & Johnson COVID vaccine across Europe has been delayed, while US officials have recommended a "pause" in the use of the jab as reports of blood clots are investigated.Sky News - Published | US recommends 'pause' to Johnson & Johnson jab rollout over blood clot fearsThe US Food and Drug Administration has recommended a "pause" to the rollout of the Johnson & Johnson COVID vaccine so it can investigate reports of blood clots.Sky News - Published |
J&J in talks to start bridging clinical studyIndiaTimes - Published | EU regulator reviewing possible links between Johnson & Johnson jab and blood clotsEurope's drugs regulator is reviewing possible links between blood clots and Johnson & Johnson's coronavirus vaccine.Sky News - Published |
Johnson & Johnson says in talks with Indian govt for trial of single-dose vaccineIndiaTimes - Published |